Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study.
Eur J Hosp Pharm
; 29(4): 207-211, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-33051194
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Heterocyclic Compounds, 3-Ring
Type of study:
Observational_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Eur J Hosp Pharm
Year:
2022
Document type:
Article
Affiliation country:
Spain
Country of publication:
United kingdom